TCI Biotech to Unveil New Vision at Vitafoods Europe 2025: CDMO+, High-Absorption Innovation, and 45 Years of Scientific Leadership

TCI Biotech to Unveil New Vision at Vitafoods Europe 2025: CDMO+, High-Absorption Innovation, and 45 Years of Scientific Leadership

BARCELONA, Spain, May 19, 2025 /PRNewswire/ -- TCI Biotech, a global leader in health and wellness innovation, will mark a major milestone at Vitafoods Europe 2025 with a dynamic showcase of its rebranded identity, next-gen CDMO+ model, and advanced...

TCI Biotech Expands US Glass Bottling Capabilities for Liquid Nutraceuticals Innovation

TCI Biotech Expands US Glass Bottling Capabilities for Liquid Nutraceuticals Innovation

TAIPEI, April 3, 2025 /PRNewswire/ -- TCI Biotech (TCI Co., Ltd.), a CDMO+ organization specializing in health and wellness products, is spotlighting its comprehensive US-based glass bottling solution for liquid supplements, positioning it as a...

TCI Biotech Announces Strong 2024 Financial Performance, Sets Sights on Global Growth in 2025

TCI Biotech Announces Strong 2024 Financial Performance, Sets Sights on Global Growth in 2025

TAIPEI, March 10, 2025 /PRNewswire/ -- TCI Biotech (TCI Co., Ltd.) (TWSE: 8436), a leading CDMO+ innovator in health food and skincare biotechnology, has released its consolidated financial results for the fiscal year ending December 31, 2024. The...

menu
menu